HGEN - Humanigen, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 17.91M
Enterprise value -3.75M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)5.34
Price/book (mrq)N/A
Enterprise value/revenue -2.21
Enterprise value/EBITDA 0.07

Trading information

Stock price history

Beta (5Y monthly) -0.86
52-week change 3-93.12%
S&P500 52-week change 31.77%
52-week high 33.2500
52-week low 30.0900
50-day moving average 30.1534
200-day moving average 30.1691

Share statistics

Avg vol (3-month) 31.3M
Avg vol (10-day) 3893.81k
Shares outstanding 5119.08M
Implied shares outstanding 6N/A
Float 8110.2M
% held by insiders 110.51%
% held by institutions 15.88%
Shares short (14 May 2023) 44.43M
Short ratio (14 May 2023) 43.39
Short % of float (14 May 2023) 44.15%
Short % of shares outstanding (14 May 2023) 43.72%
Shares short (prior month 13 Apr 2023) 45.82M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 313 Sept 2020
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 313 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-3,061.21%

Management effectiveness

Return on assets (ttm)-85.05%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.7M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-78.70%
Gross profit (ttm)N/A
Net income avi to common (ttm)-53.63M
Diluted EPS (ttm)-0.5200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.1M
Total cash per share (mrq)0.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.09
Book value per share (mrq)-0.42

Cash flow statement

Operating cash flow (ttm)-64.31M
Levered free cash flow (ttm)-45.92M